
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Intrinsic Value
The intrinsic value of one
SUNPHARMA
stock under the Base Case scenario is
1 079.36
INR.
Compared to the current market price of 1 731.45 INR,
Sun Pharmaceutical Industries Ltd
is
Overvalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sun Pharmaceutical Industries Ltd
Fundamental Analysis


Sun Pharma’s reliance on the U.S. specialty and generics market leaves it vulnerable to aggressive pricing pressure, which could compress margins and slow top-line growth if insurers and pharmacy benefit managers continue to push for lower prices.
A well-rounded specialty portfolio—particularly in high-growth areas such as dermatology, ophthalmology, and oncology—positions Sun Pharma to command premium pricing and drive robust profit expansion in global markets.

Revenue & Expenses Breakdown
Sun Pharmaceutical Industries Ltd
Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd
Current Assets | 460.7B |
Cash & Short-Term Investments | 207.6B |
Receivables | 129.9B |
Other Current Assets | 123.2B |
Non-Current Assets | 420.5B |
Long-Term Investments | 68.1B |
PP&E | 112.5B |
Intangibles | 182.2B |
Other Non-Current Assets | 57.7B |
Free Cash Flow Analysis
Sun Pharmaceutical Industries Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Sun Pharmaceutical Industries Ltd
Revenue
|
516B
INR
|
Cost of Revenue
|
-104.9B
INR
|
Gross Profit
|
411.1B
INR
|
Operating Expenses
|
-288.6B
INR
|
Operating Income
|
122.5B
INR
|
Other Expenses
|
-8.1B
INR
|
Net Income
|
114.3B
INR
|
SUNPHARMA Profitability Score
Profitability Due Diligence
Sun Pharmaceutical Industries Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Score
Sun Pharmaceutical Industries Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
SUNPHARMA Solvency Score
Solvency Due Diligence
Sun Pharmaceutical Industries Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Score
Sun Pharmaceutical Industries Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA
is 2 062.75 INR
with a low forecast of 1 489.75 INR and a high forecast of 2 572.5 INR.
Dividends
Current shareholder yield for SUNPHARMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SUNPHARMA
stock under the Base Case scenario is
1 079.36
INR.
Compared to the current market price of 1 731.45 INR,
Sun Pharmaceutical Industries Ltd
is
Overvalued by 38%.